Loading [MathJax]/extensions/MathML/content-mathml.js
info@auctorespublishing.com
+1-(302)-520-2644
+1-(302)-520-2644

Do Patients Correctly Use Steroid Nose Spray? A Patient-Reported Survey of the Nasal Spray Technique and Patient Compliance

  1. Home
  2. Journals
  3. Journal of Clinical Otorhinolaryngology
  4. Archives
Submit Guidelines

Research Article | DOI: https://doi.org/10.31579/2692-9562/033

Do Patients Correctly Use Steroid Nose Spray? A Patient-Reported Survey of the Nasal Spray Technique and Patient Compliance

  • Waqas Jamil 1*
  • Abdullah Alahwal 1
  • Ravinder Suman 1
  • Megan Whitwell 1
  • Farah Naz 2
  • Thomas Beech 2

Queen Elizabeth Hospital UK

*Corresponding Author: Waqas Jamil, ENT department, Queen Elizabeth Hospital UK.

Citation: Jamil W, Alahwal A, Suman R, Whitwell M, Naz F, Beech T (2021). Do patients correctly use steroid nose spray? A patient-reported survey of the nasal spray technique and patient compliance; J. of Clinical Otorhi. 3(4). DOI: 10.31579/2692-9562/033

Copyright: © 2021, Waqas Jamil. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 19 April 2021 | Accepted: 22 May 2021 | Published: 20 August 2021

Keywords: nasal sprays; rhinitis; allergic

Abstract

Background:Correct nasal spray techniqueand patient compliance are the two mostimportant factors in the use of steroid nose spray.

Objectives:To find out if patientsuse steroid nasal spray with a correctspray technique and if they are compliant in using the spray.

Design: Patient-reported survey

Participants: 100 participants (1 excluded)

Main outcome measures 1) Nasal spray technique 2) Patient compliance

Results: Out of 99 participants included in this study only one patient used steroid nose spray with a completely correct spray technique. 40% of patients received guidance instructions from the prescriber about the spray technique. 70% of patients reported using their spray regularly and 53% of patients were found using the correct dosage of the spray.

Conclusions: Wrong spray technique and patient noncompliance is common and can be corrected. This survey emphasizes the importance of giving written and verbal instructions about the use of spray to the patients.

Key Points:

  • Only 1 patient out of 99, used steroid nasal spray with a completely correct spray technique.
  • Nasal spray technique was taught only to 40% of thepatients
  • 70% of the patientsreported regular use of the steroid nose spray and 53% of patients were found to use correct spray dosage.
  • Wrong spray technique and non-compliance can be the reason behind the treatment failure with steroid nasal spray.
  • We recommend following “British Society for Allergy and Clinical Immunology-how to apply a nasal spray” and/or video instruction from “asthma.org.uk- how to use nasal spray” for the correct spray technique.

Introduction

Background: Various studies conducted in the past have proven the efficacy of steroid nasal spray in the treatment of inflammatory nasal conditions. [1],[2] Currently, topical steroid nasal sprays are considered as the first-line treatment for the management of allergic rhinitis (hayfever) and chronic rhinosinusitis.[1],[3],[4],[5] Intranasal steroids work locally inside the nose and are found to be more effective than systemic steroids [2]. Local application of steroids in the nose reduces systemic absorption, hence reducing systemic side effects [6]. Various steroid- based nasal sprays are available i.e. Beconase, Nasonex, Avamys,Flixonase [7]. Combination nasal spray is also available which contains topical antihistamine and topical steroid i.e. Dymista [8].

Previous studies have investigated the correlation between the spray technique and the distribution of drug inside the nose [9],[10],[11],[12]. Correct spray technique and patient compliance are the two important factors for the nasal spray to work. Furthermore, incorrect spray technique can be associated with side effectsi.e. irritation and epistaxis [6]. Current guidance on the management of chronic rhinosinusitis, allergic and non- allergic rhinitis strongly recommends clinicians to check nasal spray technique and compliance [3], [5].

Significant material is available on the internet to educate people about nasal spray use, however, some of them are inaccurate [7, 13-16]. Therefore, after extensive research, we recommend following the written instructions for the use of steroid nasal spray from “British Societyfor Allergy and Clinical Immunology” or/and video tutorial from “ asthma.org.uk- how to use nasal spray” [7],[13] (See below). We recommend following these steps when using steroid nose spray:

  • Clear the nose.
  • Slightly bend headforward.
  • Use opposite hand when holding spray (Right hand for left nostril and left hand for right nostril).
  • Direct spray inside the nose away from nasal septum (towards turbinate) towards ipsilateral ear oreye.
  • Administer spray- avoid hard sniffing.
  • Repeat the same for the other nostril.

Objectives

The main objectives of this survey were:

  1. To investigate if patients use a correct spray technique while administering steroid nose spray.
  2. To investigate the patient's compliance in using the steroid nose spra

Methods

Study design and Setting: This survey was conducted at Queen Elizabeth Hospital in Birmingham, UK. Initially, a written paper survey form (see figure 1) was distributed among the patients who were using steroid nasal spray and who came to attend rhinology and immunology outpatient clinics. But, shortly after this survey started, face to face patient consultations were stopped due to COVID-19outbreak. Hence, a telephonic patient-reported survey was undertaken for the remaining patients. During the telephonic survey, we made a minor change in the question 3 of the survey (see figure 1)

Results andanalysis

1.Participants: Total100 patients took part in this survey. 15 patients filled in paper survey proforma before COVID-19 outbreak and the remaining 85 responded to the telephonic survey. Mean age of the participated patients in this survey was 49 years old, ranging from 18 to 77 years. There were 53 males and 46 females and the male: female ratio was 1.15:1.

  1. When analysing the patient’s responses, one respondent was using otrovine instead of steroid spray. Hence, we excluded this patient from the study, which dropped the total number of participants included in the study to 99.
    1. Patient responses: Patient responses to the survey questions are as below:
      1. Who prescribed this nose spray?
        1. ENT 53% (53 patients).
        2. GP 42% (42 patients).
        3. Over the counter 3% (3 patients).
        4. 1 % (1 patient) cannot remember who prescribed the spray
        5. No spray was prescribed by the immunologist.
        6. Were you shown how to use nose spray?
          1. 40% (40 patients) responded yes
          2. 60% (59 patients) responded No
figure 1

Further breakdown of the taught spray technique in those 40% cases was:

  1. 24% of cases (24 patients) by the ENT team.
  2. 15% of cases (15 patients) by GP.
  3. 1% of cases (1 case) by an asthma nurse.
    1. Outcome Data:
      1. Spray technique: Majority of the patients were using steroid nose spray with an incorrectspray technique. Only 1 patientout of 99 used steroid nose spray in a completely correct manner i.e. followed each step correctly. Different steps in using nose spray were all analysed separately i.e. head position, the direction of spray inside the nose, hand preference for holding spray bottle, sniffing, tasting spray in the mouth (See figure 2).
      2. Patient compliance: Compliance issues were also identified in the use of steroid nose spray. Majorityof the patients revealed “regular” use of the spray 70% (69 patients). However,some patients reported using their spray “most of the times” 14% (14 patients) and “sometimes” 16% (16 patients) respectively. 53% of patients were found using correct spray dose but 34% (34 patients) were using the incorrect dose of the prescribed spray; either underdosing or overdosing. 13% (13 patients) were unable to recall the spray name, neither we were able to find the spray name in our documentation. Hence, we can not comment whetherthey used correctspray dosage (See figure 3).
figure 2
figure 3
  1. Nasal sprays: Below is the list of nasal spraysand the percentage of patients using these sprays:
  • Dymista 33 patients(34%)
  • Nasonex 21 patients(21%)
  • Avamys 23 patients(23%)
  • Flixonase 4 patients (4%)
  • Beconase 4 patients(4%)
  • Budenasoide 1 patient (1%)
  • 13 patients cannotremember the name of the spray (13%).

Conclusion

Wrong spray technique is extremely common among patients using the steroid nose spray. This seems to be overlooked by many clinicians, which is easily correctable. Moreover, patient compliance can be further improved. We emphasize the importance of giving verbal as well as written instructions to the patients when prescribing steroid nose spray.

  1. Ethical considerations: This survey was registered with clinical audit registration and management system CARMS- 15756 in Queen Elizabeth Hospital Birmingham, UK.
  2. Conflicts of Interest: None declared
  3. Data availability statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.4.
  4. Funding: No funding

References

  1. Penagos M, Compalati E, Tarantini F, Baena-Cagnani C, Passalacqua G, et.al. (2008). Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy; 63(10):1280-1291.
    View at Publisher | View at Google Scholar
  2. Rodrigo G, Neffen H. (2011). Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin Exp Allergy; 41(2):160-170.
    View at Publisher | View at Google Scholar
  3. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps. Rhinol; 58(29):1-464.
    View at Publisher | View at Google Scholar
  4. National Institute for Health and Care Excellence[internet]. Allergic Rhinitis.
    View at Publisher | View at Google Scholar
  5. Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, et al. (2007). BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis. Clin Exp Allergy; 47(7):856-889.
    View at Publisher | View at Google Scholar
  6. Ganesh V, Banigo A, McMurran A, Shakeel M, Ram B. (2017). Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey. J Laryngol ;131(11):991- 996.
    View at Publisher | View at Google Scholar
  7. Bscai improving allergy car.Topical Nasal Steroid Spray; 2017. 8. Dymista; 2020
    View at Publisher | View at Google Scholar
  8. Merkus P, Ebbens FA, Muller B, Fokkens WJ. (2006). The 'best method' of topical nasal drug delivery: comparison of seven techniques. Rhinol; 44(2):102-107.
    View at Publisher | View at Google Scholar
  9. Bateman N, Whymark A, Clifton N, Woolford T. (2002). A study of intranasal distribution of azelastine hydrochloride aqueous nasal spray with different spray techniques. Clin Otolaryngol Allied Sci; 27(5):327-330.
    View at Publisher | View at Google Scholar
  10. Tsikoudas A, Homer J. (2008). The delivery of topical nasal sprays and drops to the middle meatus: a semiquantitative analysis. Clin Otolaryngol Allied Sci; 26(4):294-297.
    View at Publisher | View at Google Scholar
  11. Aggarwal R, Cardozo A, Homer J. (2004). The assessment of topical nasal drug distribution. Clin Otolaryngol Allied Sci; 29(3):201-205.
    View at Publisher | View at Google Scholar
  12. Asthma UK. (2020). How to Use Nasal Spray.
    View at Publisher | View at Google Scholar
  13. American Family Physician. (2000). Nasal Sprays: How to Use Them Correctly.
    View at Publisher | View at Google Scholar
  14. Family doctor.org. (2000). Nasal Sprays: How to Use Them Correctly.
    View at Publisher | View at Google Scholar
  15. Flonase. HOW TO GET COMFORTABLE WITH NASAL SPRAYS (YOUR NOSE WILL THANK YOU)
    View at Publisher | View at Google Scholar
  16. Nasal Sprays: How to Use Them Correctly
    View at Publisher | View at Google Scholar
  17. Nabi S, Rotenberg BW, Vukin I, Payton K, Bureau Y. (2012). Nasal Spray Adherence after Sinus Surgery: Problems and Predictors. J Otolaryngol Head Neck Surg; (1):S49-55.
    View at Publisher | View at Google Scholar
  18. Baddar S, Jayakrishnan B, Al-Rawas OA. (2014). Asthma control: importance of compliance and inhaler technique assessments. Asthma Res Pract; 51(4):429-434.
    View at Publisher | View at Google Scholar
  19. 20. Hamdan A, Ahmed A, Abdullah A, Khan M, Baharoon S, et al. (2013) Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol; 9(1):8.
    View at Publisher | View at Google Scholar
  20. 21. Kebede B, Mamo G, Molla A. (2019). Association of Asthma Control and Metered-Dose Inhaler Use Technique among Adult Asthmatic Patients Attending Outpatient Clinic, in Resource- Limited Country: A Prospective Study.Allergy Asthma Clin Immunol.
    View at Publisher | View at Google Scholar
a